Viewing nowLipican Tablet 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

MFDS item code 200703136 · Notified 2007.03.13 · Insurance code 653801370
Reduction of the risk of myocardial infarction and stroke, and improvement of hyperlipidemia
This medication helps reduce the risk of cardiovascular diseases. It particularly lowers the risk of myocardial infarction and stroke, and also reduces the risk of vascular surgeries and angina. It is effective at managing multiple risk factors for cardiovascular diseases in diabetic patients. In patients with hyperlipidemia, it helps improve vascular health by regulating cholesterol and triglyceride levels. Additionally, it aids in the prevention of heart disease in pediatric patients with familial hypercholesterolemia. Overall, it is used to improve cardiovascular health and reduce risks.
For the treatment of hyperlipidemia, the recommended starting dose is 10 mg once daily. If a greater reduction in LDL cholesterol is required, therapy can be initiated at 20 mg or 40 mg once daily. The dosage should be adjusted within the range of 10–80 mg once daily, individualizing based on treatment goals and patient response, with lipid levels being analyzed every 2 to 4 weeks after initiation and/or dose adjustment. As the treatment goal is to lower LDL cholesterol levels, it is recommended to use LDL cholesterol measurements to evaluate the start of treatment and treatment response. However, if LDL cholesterol levels are not available, total cholesterol levels should be used to monitor treatment response. For patients with homozygous familial hypercholesterolemia, the dosing regimen is 10–80 mg once daily, given in conjunction with other lipid-lowering therapies (e.g., LDL apheresis) or in cases where such therapies are not possible. For pediatric patients with heterozygous familial hypercholesterolemia (ages 10–17), the recommended starting dose is 10 mg once daily with a recommended maximum of 20 mg once daily (there are no clinical data for doses above 20 mg in this patient group). Dosing should be appropriately adjusted based on the recommended treatment goals for individual patients, with doses being adjusted every 4 weeks or longer if necessary. ○ In patients with kidney disease: Kidney disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect, so there is no need to adjust the dosage. ○ In elderly patients: Effectiveness and safety in patients aged 70 and over are similar to those in the general adult patient population.
For pediatric patients with heterozygous familial hypercholesterolemia (ages 10–17), the recommended starting dose is 10 mg once daily, with a recommended maximum dose of 20 mg once daily. Dosing should be adjusted appropriately based on the patient's treatment goals.
This drug may pose a risk of muscle problems; therefore, if symptoms of muscle pain or weakness occur, you should stop taking it immediately and consult a doctor. Patients with liver dysfunction or severe liver disease should not use this medication and should undergo regular liver function tests during treatment. Women who are pregnant or may become pregnant should not take this medication and must use proper contraceptive methods while on it. This drug may increase the risk of side effects when taken with certain medications, so if you are taking other drugs, you should inform your doctor or pharmacist. Elderly patients or those with decreased kidney function are at higher risk for muscle-related side effects, so caution is needed during use, and symptoms should be reported immediately. This medication contains lactose, so individuals with lactose intolerance should not take it. Since there is no specific antidote for overdose, if an overdose occurs, immediate medical treatment should be sought, and liver function and muscle status should be carefully monitored. Keep out of reach of children, store in the original container to prevent misuse or deterioration in quality. If allergic reactions such as skin rash, itching, or difficulty breathing occur, stop taking this medication immediately and consult medical personnel.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pale appearance, severe allergic reactions, high fever with severe rash, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory distress accompanied by cough and fever, breathing problems, yellowing of the skin or eyes (jaundice), extreme lethargy, liver anomalies (jaundice), sudden and
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that is not exposed to air, preferably at room temperature between 1 and 30 degrees Celsius. By storing it this way, you can maintain the effectiveness of the medicine for an extended period.
White oval film-coated tablet
30 tablets/bottle, 120 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.